Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma (PTCL)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Fudan University.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Fudan University
ClinicalTrials.gov Identifier:
NCT00974324
First received: September 9, 2009
Last updated: September 14, 2010
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)